en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
3/2021
vol. 123
 
Share:
Share:
more
 
 
abstract:
Review paper

Phytocannabinoids and the eye – a systematic review

Anna Wolnik
1
,
Małgorzata Woś
1
,
Jerzy Mackiewicz
2

1.
Division of Ophthalmology with the Children’s Ophthalmology Subunit, Stefan Żeromski Specialist Hospital in Krakow, Poland
2.
Department of Retinal and Vitreous Surgery, Medical University of Lublin, Poland
KLINIKA OCZNA 2021, 123, 3: 114–121
Online publish date: 2021/10/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Recently, the use of marihuana for medical purposes has become more common. It can lead to many desired effects within the eye, as well as several adverse ones (i.a.: decrease in intraocular pressure, reduction of corneal pain and suppression of inflammation after chemical injury of cornea, treatment of blepharospasm, reduction of nystagmus, decrease in corneal endothelial cell density, eye irritation). There have not been enough studies with human subjects done on the safety and effectiveness of cannabis use in ophthalmology. Although synthetic cannabinoids combined with modulation of the endocannabinoid system might become the future of ophthalmology, more studies on this topic should be conducted.
keywords:

marijuana (marihuana), medical marijuana (marihuana), phytocannabinoids, Δ-9-tetrahydrocannabinol

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.